ANCA相关性小血管炎性肾损害的治疗分为三个阶段：诱导缓解、维持缓解的治疗以及复发的治疗。诱导期通常维持3~6个月，必须持续至病情缓解为止，病情缓解后维持治疗时间一般持续24个月左右。目前，ANCA相关性小血管炎性肾损害仍无标准的治疗方案，糖皮质激素 ...

mumc.nl Background: Antineutrophil cytoplasmic antibodies (ANCA) with a C-ANCA or P-ANCA pattern are detected in ANCA-associated vasculitis (AAV). While in most patients with AAV a C-ANCA pattern is ...

OSAKA, Japan & BOSTON, MA, USA I June 23, 2025 I Ono Pharmaceutical Co., Ltd. (Headquarters: Osaka, Japan; President and COO: Toichi Takino; “Ono”) and ...

A team studied the differences between monogenic and nonmonogenic lupus nephritis and the predictors of end-stage kidney disease.

The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...

Sanofi's rash of dealmaking has continued with a $2.5 billion tie-up with Chinese cancer immunotherapy biotech Adagene, focused on developing a new generation of safer antibody-based therapies.

He, L., Zhou, Y., Wang, Q.T., Liu, J. and Ma, J.P. (2025) Two Pathological Patterns in Different Stages of the Same Disease. Journal of Biosciences and Medicines, 13, 189-195. doi: ...

Department of Rheumatology and Immunology, Laboratory of Rheumatology and Immunology, Institutes for Systems Genetics, West China Hospital, Sichuan University, Chengdu, China Introduction: ...

WAYNE, Pa., June 18, 2025 (GLOBE NEWSWIRE) -- Avalo Therapeutics, Inc. (Nasdaq: AVTX), a clinical stage biotechnology company ...

Passive anti-D immune globulin administered to prevent anti-D antibody formation in RhD-negative women who carry and are exposed to RhD-positive fetal RBCs; once called Rh "sensitization," this is ...